Article
In vitro evolution predicts emerging SARS-CoV-2 mutations with high affinity for ACE2 and cross-species binding.
PLoS pathogens - 1 Jul 2022
Bate Neil, Savva Christos G, Moody Peter C E, Brown Edward A, Evans Sian E, Ball Jonathan K, Schwabe John W R, Sale Julian E, Brindle Nicholas P J
Abstract excerpt
Emerging SARS-CoV-2 variants are creating major challenges in the ongoing COVID-19 pandemic. Being able to predict mutations that could arise in SARS-CoV-2 leading to increased transmissibility or immune evasion would be extremely valuable in development of broad-acting therapeutics and vaccines, and prioritising viral monitoring and containment. Here we use in vitro evolution to seek mutations in SARS-CoV-2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
